Yun‐Gyoo Lee

2.2k total citations
72 papers, 942 citations indexed

About

Yun‐Gyoo Lee is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Yun‐Gyoo Lee has authored 72 papers receiving a total of 942 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 30 papers in Oncology and 15 papers in Surgery. Recurrent topics in Yun‐Gyoo Lee's work include Lung Cancer Treatments and Mutations (22 papers), Head and Neck Cancer Studies (10 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Yun‐Gyoo Lee is often cited by papers focused on Lung Cancer Treatments and Mutations (22 papers), Head and Neck Cancer Studies (10 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Yun‐Gyoo Lee collaborates with scholars based in South Korea, United States and Taiwan. Yun‐Gyoo Lee's co-authors include Hye Ryun Kim, Myung‐Ju Ahn, Ki Hyeong Lee, Bong-Seog Kim, Jong-Seok Lee, Young Joo Min, Byoung Chul Cho, Dong‐Hoe Koo, Joo-Hang Kim and Keun‐Wook Lee and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Yun‐Gyoo Lee

64 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yun‐Gyoo Lee South Korea 15 436 430 233 123 119 72 942
Ignacio Escobar Spain 17 243 0.6× 417 1.0× 165 0.7× 92 0.7× 48 0.4× 63 950
Leila A. Kutteh United States 14 634 1.5× 117 0.3× 154 0.7× 144 1.2× 177 1.5× 23 995
Hasan Mutlu Türkiye 16 435 1.0× 180 0.4× 89 0.4× 116 0.9× 42 0.4× 69 726
Kefeng Wang China 19 301 0.7× 157 0.4× 237 1.0× 190 1.5× 34 0.3× 41 896
Tao Jin China 18 288 0.7× 289 0.7× 203 0.9× 83 0.7× 78 0.7× 73 1.0k
Yaşar Yıldız Türkiye 18 381 0.9× 138 0.3× 128 0.5× 107 0.9× 42 0.4× 67 798
Vishal Ranpura United States 5 393 0.9× 202 0.5× 196 0.8× 85 0.7× 28 0.2× 12 846
Renata D’Alpino Peixoto Brazil 17 569 1.3× 320 0.7× 119 0.5× 164 1.3× 17 0.1× 95 964
Maria Albertsson Sweden 17 504 1.2× 260 0.6× 46 0.2× 77 0.6× 34 0.3× 35 877

Countries citing papers authored by Yun‐Gyoo Lee

Since Specialization
Citations

This map shows the geographic impact of Yun‐Gyoo Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yun‐Gyoo Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yun‐Gyoo Lee more than expected).

Fields of papers citing papers by Yun‐Gyoo Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yun‐Gyoo Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yun‐Gyoo Lee. The network helps show where Yun‐Gyoo Lee may publish in the future.

Co-authorship network of co-authors of Yun‐Gyoo Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Yun‐Gyoo Lee. A scholar is included among the top collaborators of Yun‐Gyoo Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yun‐Gyoo Lee. Yun‐Gyoo Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cho, Byoung Chul, Ji‐Youn Han, Ki Hyeong Lee, et al.. (2024). Lazertinib as a frontline treatment in patients with EGFR-mutated advanced non-small cell lung cancer: Long-term follow-up results from LASER201. Lung Cancer. 190. 107509–107509. 4 indexed citations
2.
3.
4.
Lim, Seung Taek, Hye Ryun Kim, Eun Joo Kang, et al.. (2024). Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study. Oral Oncology. 151. 106739–106739. 2 indexed citations
5.
6.
Lim, Sun Min, Hee Kyung Ahn, Yun‐Gyoo Lee, et al.. (2023). A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial. Cancer Research and Treatment. 56(1). 37–47. 4 indexed citations
7.
8.
Kwon, MiYoung, et al.. (2023). Predicting tolerability of high-dose fentanyl buccal tablets in cancer patients. PLoS ONE. 18(1). e0280212–e0280212.
9.
Choi, Jung‐Yeon, Ji Yeon Lee, Jaeyong Shin, et al.. (2022). COMPrehensive geriatric AsseSSment and multidisciplinary team intervention for hospitalised older adults (COMPASS): a protocol of pragmatic trials within a cohort. BMJ Open. 12(8). e060913–e060913. 6 indexed citations
10.
11.
Hong, Min Hee, Seong Gu Heo, Yun‐Gyoo Lee, et al.. (2020). Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma. Cancer. 126(20). 4521–4531. 10 indexed citations
12.
Park, Ji Hyun, Sang Hoon Chun, Yun‐Gyoo Lee, et al.. (2020). Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12. Journal of Cancer Research and Clinical Oncology. 146(12). 3359–3369. 14 indexed citations
13.
Lee, Yun‐Gyoo, Hyun Chang, Bhumsuk Keam, et al.. (2020). Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12. Cancer Research and Treatment. 53(3). 671–677. 20 indexed citations
14.
Lee, Yun‐Gyoo, Chi Hoon Maeng, Do Yeun Kim, & Bong-Seog Kim. (2020). Perspectives on Professional Burnout and Occupational Stress among Medical Oncologists: A Cross-sectional Survey by Korean Society for Medical Oncology (KSMO). Cancer Research and Treatment. 52(4). 1002–1009. 10 indexed citations
15.
16.
Cho, Byoung Chul, Sun Min Lim, Hye Ryun Kim, et al.. (2017). MA07.07 Ceritinib in ROS1-Rearranged Non-Small-Cell Lung Cancer: An Update of Korean Nationwide Phase II Study. Journal of Thoracic Oncology. 12(1). S381–S382. 1 indexed citations
17.
Lee, Yun‐Gyoo, Dong‐Hoe Koo, Sukjoong Oh, et al.. (2015). Efficacy and safety of ifosfamide in combination with carboplatin and etoposide in small cell lung cancer. Cancer Chemotherapy and Pharmacology. 76(5). 933–937. 4 indexed citations
18.
Yoon, Sung Soo, Jae‐Ho Yoon, Seung‐Hwan Shin, et al.. (2014). Implications of cytogenetics for venous thromboembolism in acute myeloid leukaemia. Thrombosis and Haemostasis. 113(1). 201–208. 18 indexed citations
19.
20.
Lee, Yun‐Gyoo, Sae‐Won Han, Do‐Youn Oh, et al.. (2011). Diagnostic performance of contrast enhanced CT and 18F-FDG PET/CT in suspicious recurrence of biliary tract cancer after curative resection. BMC Cancer. 11(1). 188–188. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ignacio Escobar Breakdown of academic impact, for papers by Leila A. Kutteh Breakdown of academic impact, for papers by Hasan Mutlu Breakdown of academic impact, for papers by Kefeng Wang Breakdown of academic impact, for papers by Tao Jin Breakdown of academic impact, for papers by Yaşar Yıldız Breakdown of academic impact, for papers by Vishal Ranpura Breakdown of academic impact, for papers by Renata D’Alpino Peixoto Breakdown of academic impact, for papers by Maria Albertsson
Rankless by CCL
2026